Immunoassay in healthcare testing applications
| Autor: | Timothy A. Robert, Anne Z. DePriest, David L. Black |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Drug
Drugs of abuse medicine.medical_specialty Prescription drug media_common.quotation_subject Population Urinalysis Pharmacology Specimen Handling Benzodiazepines Predictive Value of Tests Health care Humans Medicine False Positive Reactions Pharmacology (medical) Intensive care medicine education False Negative Reactions media_common Immunoassay education.field_of_study medicine.diagnostic_test business.industry Reproducibility of Results General Medicine Pain management Opioid-Related Disorders Analgesics Opioid Substance Abuse Detection Anesthesiology and Pain Medicine Chronic Pain Drug Monitoring business Biomarkers |
| Zdroj: | Journal of Opioid Management. 11:13-25 |
| ISSN: | 1551-7489 |
| Popis: | Immunoassay is used extensively for drug testing in pain management. Drug testing for the purpose of compliance monitoring is fundamentally different from forensic applications, which may rely on immunoassay screening to rapidly identify "negative" samples. In clinical settings, focus is shifted from identification of select drugs of abuse with low positivity rates to detection of a wide variety of licit and illicit compounds with expected high positivity rates. The primary drug classes of interest in this population, opioids and benzodiazepines, require special testing considerations when immunoassay is used. This review highlights the performance characteristics of immunoassay, with special emphasis on prescription drug classes and testing at the point-of-care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|